Quick answer
This page lists 71 immunotherapy doctors in India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.
About Immunotherapy doctors in India
This directory is based on doctors currently listed in GAF Healthcare's registry. Clinical suitability varies by patient; a doctor should review your history and investigations before any treatment decision.
Immunotherapy doctors
FeaturedDr. Vinod Raina
MBBS, MD (Internal Medicine), DM (Medical Oncology), Fellowship, Fellowship
Chairman – Medical Oncology · Specialty: Medical Oncologist
Fortis Memorial Research Institute Gurgaon, India40+ Years experience
Why consider this doctor?
- 40+ years of experience in Medical Oncologist
- Chairman – Medical Oncology, Fortis Memorial Research Institute, Gurugram (Present)
- Professor and Head of Medical Oncology, AIIMS, New Delhi (2001 – 2013)
Expertise & Procedures
- High-Dose Chemotherapy with Stem Cell Rescue
- Autologous Bone Marrow Transplant
- Chemotherapy (Induction, Consolidation, Maintenance)
- Concurrent Chemoradiotherapy
- Palliative Chemotherapy
Medical Oncologist Experience: 40+ YearsHospital Affiliation: Fortis Memorial Research InstituteHospital accreditation: JCI, NABH
Dr. Pooja Babbar
MBBS, MD Radiation Oncology, Senior Residency, DM Medical Oncology – Gold Medalist, European Certification in Medical Oncology (ESMO), Diploma in Medico Legal System, MBA in Hospital Management
Consultant & Unit Head – Medical Oncology · Specialty: Medical Oncologist
Fortis Hospital Manesar Gurugram, India11+ Years experience
Why consider this doctor?
- 11+ years of experience in Medical Oncologist
- Consultant & Unit Head – Medical Oncology, Fortis Hospital, Manesar, Gurugram (Present)
- American Oncology Institute, Gurugram
Expertise & Procedures
- Chemotherapy (Adjuvant, Neoadjuvant, Palliative)
- Immunotherapy (Checkpoint Inhibitors)
- Targeted Therapy (HER2, EGFR, VEGF, CDK4/6 inhibitors)
- Hormonal Therapy (Breast, Prostate cancer)
- Oncological Emergency Management
Medical Oncologist Experience: 11+ YearsHospital Affiliation: Fortis Hospital ManesarHospital accreditation: NABH, NABL, JCI
Dr. Ashok Kumar Vaid
MBBS, MD (General Medicine), DM (Medical Oncology)
Chairman — Medical Oncology, Hematology & Stem Cell Transplant · Specialty: Medical Oncologist & BMT Specialist
Medanta - The Medicity Gurgaon, India44+ Years experience
Why consider this doctor?
- 44+ years of experience in Medical Oncologist & BMT Specialist
- Chairman — Medical Oncology, Hematology & Stem Cell Transplant, Medanta – The Medicity, Gurgaon (Present)
- Pioneered one of the largest stem cell transplant programmes in private-sector north India
Expertise & Procedures
- Allogeneic Stem Cell Transplant
- Autologous Stem Cell Transplant
- Haploidentical Stem Cell Transplant
- Bone Marrow Aspiration & Biopsy
- Chemotherapy Administration
Medical Oncologist & BMT Specialist Experience: 44+ YearsHospital Affiliation: Medanta - The MedicityHospital accreditation: JCI, NABH
Dr. Imran Khan
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP — Medical Oncology
Consultant — Medical Oncology · Specialty: Medical Oncologist
Fortis Escorts Heart Institute New Delhi, India10+ Years experience
Why consider this doctor?
- 10+ years of experience in Medical Oncologist
- Consultant — Medical Oncology, Fortis Escorts, Okhla Road, New Delhi (Present)
- Associate Consultant — Medical Oncology, Fortis Escorts, Amritsar
Expertise & Procedures
- Chemotherapy Administration
- Targeted Therapy Infusions
- Immunotherapy Infusions
- PICC Line Insertion
- Bone Marrow Aspiration & Biopsy
Medical Oncologist Experience: 10+ YearsHospital Affiliation: Fortis Escorts Heart InstituteHospital accreditation: JCI, NABH
Dr. Huma Noor
MBBS, MD (General Medicine), DM (Medical Oncology), MRCP — Medical Oncology
Consultant — Medical Oncology · Specialty: Medical Oncologist
Fortis Escorts Heart Institute New Delhi, India11+ Years experience
Why consider this doctor?
- 11+ years of experience in Medical Oncologist
- Consultant — Medical Oncology, Fortis Escorts, Okhla Road, New Delhi (Present)
- Consultant — Medical Oncology, Fortis Escorts, Amritsar
Expertise & Procedures
- Chemotherapy Administration
- Immunotherapy Infusions
- Targeted & Hormonal Therapy
- Autologous Stem Cell Transplant
- Allogeneic Stem Cell Transplant (Paediatric & Adult)
Medical Oncologist Experience: 11+ YearsHospital Affiliation: Fortis Escorts Heart InstituteHospital accreditation: JCI, NABH
Dr. Dipanjan Panda
MBBS, MD (General Medicine), DM (Medical Oncology)
Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Indraprastha Apollo Hospitals New Delhi, India15+ Years experience
Why consider this doctor?
- 15+ years of experience in Medical Oncologist
- Senior Consultant — Medical Oncology, Indraprastha Apollo Hospitals, New Delhi (Present)
- Associate Professor & HOD — Medical Oncology, Institute of Liver and Biliary Sciences (ILBS), New Delhi
Expertise & Procedures
- Systemic chemotherapy for solid tumours
- Targeted therapy regimens
- Immunotherapy (checkpoint inhibitors)
- Oral chemotherapy management
- Adjuvant and neo-adjuvant cancer treatment planning
Medical Oncologist Experience: 15+ YearsHospital Affiliation: Indraprastha Apollo Hospitals
Dr. Ajay Sharma
MBBS, MD, DNB, ECMO
Senior Director & Unit Head — Medical Oncology · Specialty: Medical Oncologist
BLK-Max Super Speciality Hospital New Delhi, India18+ Years experience
Why consider this doctor?
- 18+ years of experience in Medical Oncologist
- Senior Director and Unit Head, Medical Oncology — BLK-Max Super Speciality Hospital, New Delhi (Present)
- Unit Head and Senior Consultant, Medical Oncology — Rajiv Gandhi Cancer Institute and Research Centre, New Delhi (2022–2023)
Expertise & Procedures
- Adjuvant chemotherapy for solid tumours
- Neoadjuvant chemotherapy planning and delivery
- Immunotherapy and checkpoint inhibitor therapy
- Hormone therapy for breast cancer
- Molecular-targeted therapy based on biomarkers
Medical Oncologist Experience: 18+ YearsHospital Affiliation: BLK-Max Super Speciality HospitalHospital accreditation: JCI, NABH
Dr. Akshay Shah
MBBS, DNB, Fellowship in Stem Cell Transplantation
Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Gleneagles Global Hospitals Mumbai, India22+ Years experience
Why consider this doctor?
- 22+ years of experience in Medical Oncologist
- Senior Consultant — Medical Oncology, Gleneagles Global Hospitals, Mumbai — Present
- Specialist in Hematology and Bone Marrow Transplantation, Gleneagles Hospitals Parel, Mumbai
Expertise & Procedures
- Allogeneic and Autologous Stem Cell Transplantation
- Bone Marrow Aspiration and Biopsy
- Intrathecal Chemotherapy Injections
- Lumbar Puncture (Spinal Tap)
- Pleurodesis
Medical Oncologist Experience: 22+ YearsHospital Affiliation: Gleneagles Global HospitalsHospital accreditation: NABH, JCI
Dr. Ankit Jain
MBBS, MRCP, MSc Oncology
Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Indraprastha Apollo Hospital New Delhi, India22+ Years experience
Why consider this doctor?
- 22+ years of experience in Medical Oncologist
- Senior Consultant – Medical Oncology, Indraprastha Apollo Hospital, New Delhi, India (Present)
- Consultant Medical Oncologist, Apollo Athena Women's Cancer Centre, New Delhi, India (Present)
Expertise & Procedures
- Personalized Chemotherapy Planning
- Cancer Immunotherapy Administration
- Targeted Molecular Therapy
- Hormone Replacement Therapy for Cancer
- CAR-T Cell Therapy Coordination
Medical Oncologist Experience: 22+ YearsHospital Affiliation: Indraprastha Apollo HospitalHospital accreditation: JCI, NABH
Dr. Ankur Mudgal
MBBS, MD, DNB, Preceptorship in Immuno-Oncology
Consultant — Medical Oncology · Specialty: Medical Oncologist
Medanta - The Medicity Gurugram, India10+ Years experience
Why consider this doctor?
- 10+ years of experience in Medical Oncologist
- Consultant — Medical Oncology, Medanta – The Medicity, Gurugram, India — Present
- Over 10 years of clinical experience in medical oncology and hematological malignancies
Expertise & Procedures
- Chemotherapy Administration
- Immunotherapy and Checkpoint Inhibitor Therapy
- Targeted Molecular Therapy
- Hormone Replacement Therapy
- Palliative Chemotherapy
Medical Oncologist Experience: 10+ YearsHospital Affiliation: Medanta - The MedicityHospital accreditation: JCI, NABH
Hospitals where these doctors practise
🇮🇳 Manesar, Gurgaon, IndiaStarting from$1,000
Fortis Hospital Manesar
Est. 2013
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditationJCI — Joint Commission International accreditation
ImmunotherapyMedical OncologyCardiac SurgeryOrthopedics
1+
Doctors for Immunotherapy
4.4
74 reviews
350+
Beds
13+
Years Since Founded
🇮🇳 Gurgaon, IndiaStarting from$1,000
Medanta - The Medicity
Est. 2009
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
ImmunotherapyMedical OncologyCardiac SurgeryCardiology
9+
Doctors for Immunotherapy
4.9
2150 reviews
1600+
Beds
17+
Years Since Founded
🇮🇳 New Delhi, IndiaStarting from$1,000
Fortis Escorts Heart Institute
Est. 1988
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
ImmunotherapyMedical OncologyCardiac SurgeryCardiology
2+
Doctors for Immunotherapy
4.5
24 reviews
310+
Beds
38+
Years Since Founded
🇮🇳 New Delhi, IndiaStarting from$1,000
BLK-Max Super Speciality Hospital
Est. 1959
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
ImmunotherapyMedical OncologyCardiac SurgeryCardiology
4+
Doctors for Immunotherapy
3.8
48 reviews
650+
Beds
67+
Years Since Founded
🇮🇳 Parel, Mumbai, IndiaStarting from$1,000
Gleneagles Global Hospitals (Global Hospitals)
Est. 1996
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationJCI — Joint Commission International accreditation
ImmunotherapyMedical OncologyLiver TransplantCardiac Surgery
5+
Doctors for Immunotherapy
4.6
183 reviews
450+
Beds
30+
Years Since Founded
🇮🇳 New Delhi, IndiaStarting from$1,000
Apollo Hospitals
Est. 1983
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
ImmunotherapyMedical OncologyCardiac SurgeryCardiology
6+
Doctors for Immunotherapy
4.9
1240 reviews
1000+
Beds
43+
Years Since Founded
🇮🇳 Chennai, IndiaStarting from$1,000
Gleneagles Global Hospital
Est. 1999
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationJCI — Joint Commission International accreditation
ImmunotherapyMedical OncologyCardiac SurgeryCardiology
2+
Doctors for Immunotherapy
4.7
112 reviews
1000+
Beds
27+
Years Since Founded
🇮🇳 Gurgaon, IndiaStarting from$1,000
Fortis Memorial Research Institute
Est. 1996
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
ImmunotherapyMedical OncologyCardiac SurgeryCardiology
3+
Doctors for Immunotherapy
4.8
1100 reviews
1000+
Beds
30+
Years Since Founded
Why consider treatment in India?
Many international patients consider India for colorectal cancer treatment for several reasons, including:
More affordable estimates
Competitive indicative costs compared with many other countries, for similar clinical standards.
Internationally accredited hospitals
Hospitals experienced in treating international patients.
Experienced specialists
Doctors who regularly manage similar cases.
Care coordination support
A team to help with planning, medical translation and follow-up.
About the Procedure
What is Immunotherapy?
Immunotherapy uses drugs that help the patient's own immune system recognize and destroy cancer cells, and is used across many cancers including breast, lung, colorectal, gastric/esophageal, liver/pancreatic, ovarian/gynaecological, head & neck cancers, leukemia, lymphoma, and multiple myeloma. It is given as an infusion in cycles, either alone or combined with chemotherapy/targeted therapy, and India offers globally approved immunotherapy drugs and advanced options like CAR-T cell therapy at a fraction of Western costs. Treatment plans are individualized based on tumor type, biomarker status (e.g., PD-L1, MSI), and stage of disease.
Who may be considered?
Immunotherapy may be considered after a qualified specialist reviews your reports and medical history. Suitability varies from person to person and must be assessed by your treating doctor.
How does it work?
Drugs such as PD-1/PD-L1 and CTLA-4 inhibitors are given as IV infusions every 2-4 weeks to block signals that let cancer cells evade the immune system, often combined with chemotherapy for greater effect.
3 approaches available for this procedure:
Immune Checkpoint Inhibitor Therapy
Most CommonDrugs such as PD-1/PD-L1 and CTLA-4 inhibitors are given as IV infusions every 2-4 weeks to block signals that let cancer cells evade the immune system, often combined with chemotherapy for greater effect.
Comprehensive Investigations
Estimated cost: $400 - $1,500
CBC, liver and kidney function tests, thyroid function tests, PD-L1/MSI/biomarker testing, contrast CT/PET-CT, ECG, tumor board review
Treatment / Procedure Estimate
Estimated cost in India: $1,500 - $3,500 per cycle
Stay in India
Pre-procedure stay (outside hospital): ~2-3 days
Hospitalisation: ~1 day (day-care per cycle)
Recovery period (outside hospital): ~2-3 days recommended between cycles
Total stay: approx 4-6 cycles over 3-6 months
Usually Included in Hospital Package
- Oncologist consultations
- Day-care infusion facility
- Drug administration and monitoring
- Pre-cycle blood work
- Nursing care during infusion
Usually Not Included
- Cost of immunotherapy drug (billed per cycle)
- Interim PET-CT/imaging for response assessment
- Management of immune-related side effects if hospitalization needed
- Genetic/biomarker testing not covered under package
Recovery and follow-up
Most patients tolerate immunotherapy infusions as outpatients and can resume light activity within a day or two, though fatigue, skin rash, or flu-like symptoms are common and are monitored through regular blood tests before each cycle. CAR-T patients require a longer inpatient recovery period with close monitoring for delayed immune reactions.
Risks
Immunotherapy can trigger immune-related side effects affecting the skin, gut, lungs, liver, or endocrine glands, and rarely severe reactions like cytokine release syndrome (especially with CAR-T) that require prompt hospital management. Response to treatment varies by tumor type and biomarker status, and not all patients achieve remission.
Alternatives
Depending on the cancer type and stage, alternatives include conventional chemotherapy, targeted therapy, radiation therapy, hormonal therapy, surgery, or a combination approach as advised by the tumor board.
What we need to prepare a formal estimate
Share whatever you have — the care team will confirm the final checklist after reviewing your case.
Reports required
- Histopathology and biopsy report confirming cancer type
- Biomarker/genetic testing results (PD-L1, HER2, MSI, EGFR, etc.)
- Recent CT/PET-CT/MRI imaging reports
- Complete blood count and liver/kidney function tests
- Previous chemotherapy/radiotherapy/surgery records
- Bone marrow biopsy report (for blood cancers)
- Cardiac evaluation report (ECG/ECHO)
- Discharge summaries from previous hospitalizations
Patient information needed
- Current age, weight, and general performance status
- Detailed cancer diagnosis with stage and biomarker status
- History of prior treatments and response to them
- Any known drug allergies or autoimmune conditions
- Current medications including steroids or immunosuppressants
- Presence of other chronic conditions (diabetes, heart or lung disease)
- Availability of a caregiver/attendant during treatment
- Preferred treatment start date and travel flexibility
Costs shown are indicative planning estimates based on typical pricing across leading Indian hospitals. They are not a quote — actual pricing depends on your case complexity, hospital choice, and length of stay. Share your reports for a personalized estimate.
How this directory is built
Doctors are matched using the specialty, location, condition (Immunotherapy) and procedure (Immunotherapy) recorded in their profiles. Inclusion is not an endorsement and does not guarantee a treatment outcome.
Need help with the next step?
Share your needs with our care coordination team for information about doctors and hospitals.
Common questions
FAQs about Immunotherapy in India
What is Colorectal Cancer?
Colorectal cancer is a malignancy arising from the inner lining of the colon or rectum, most often developing from adenomatous polyps that undergo cancerous change over time. It encompasses both colon cancer and rectal cancer, which share many features but may differ in their surgical and treatment approach.
What are the symptoms and health risks of Colorectal Cancer?
Common symptoms include a persistent change in bowel habits (such as diarrhoea, constipation, or narrowing of stools), rectal bleeding or blood in the stool, abdominal cramping or discomfort, a feeling that the bowel does not empty completely, unexplained weight loss, and fatigue related to anaemia from chronic blood loss. In earlier stages, many people have no noticeable symptoms at all, which underlines the importance of routine screening for eligible individuals. The presence or absence of these symptoms alone is not sufficient to confirm or rule out a diagnosis, and a thorough clinical evaluation is always required.
How is Colorectal Cancer diagnosed?
Diagnosis typically begins with a detailed medical and family history, a physical examination including digital rectal examination, and laboratory tests such as a full blood count and carcinoembryonic antigen (CEA) level. Colonoscopy is the definitive diagnostic procedure, allowing direct visualisation of the bowel lining and biopsy of any suspicious lesion for histological confirmation. Once cancer is confirmed, staging — commonly using CT scans of the chest, abdomen and pelvis, and sometimes MRI (particularly for rectal cancer) or PET-CT — is carried out to determine whether the disease is localised (Stage I–II), involves regional lymph nodes (Stage III), or has spread to distant sites (Stage IV), which directly guides treatment planning.
How is Colorectal Cancer treated?
Treatment is highly individualised and depends on the cancer's location, stage, histological type, molecular markers (such as KRAS, NRAS, BRAF, and microsatellite instability status), and the patient's overall health. Early-stage disease may be managed with surgical resection alone, while more advanced cases often require a combination of surgery, chemotherapy, targeted therapy, and in some situations immunotherapy or radiotherapy (the latter particularly for rectal cancer). All treatment decisions should be made by a qualified multidisciplinary team following thorough individual assessment.
Can Colorectal Cancer be treated without a procedure?
Non-surgical options play an important role in colorectal cancer care: chemotherapy regimens (such as FOLFOX or FOLFIRI) are used both as adjuvant treatment after surgery and as primary treatment for metastatic disease; targeted therapies (such as anti-VEGF or anti-EGFR agents) and immunotherapy (including checkpoint inhibitors for tumours with high microsatellite instability) may be recommended based on molecular profiling. For some patients with very early, superficial rectal lesions, endoscopic resection without open surgery may be appropriate. However, for the majority of confirmed colorectal cancer cases, surgery is a central component of curative-intent treatment, and whether a non-surgical pathway is suitable must be determined by a specialist team reviewing each individual case.
When is Immunotherapy considered for Colorectal Cancer?
Immunotherapy may be considered only when it is appropriate for the confirmed diagnosis and the expected benefit outweighs the individual risks. The decision may depend on symptom severity, investigation results, previous treatment, overall health and the patient's goals. A specialist should discuss alternatives and recovery before any procedure is planned.
Which doctor treats Colorectal Cancer?
Colorectal cancer is typically evaluated and managed by a surgical oncologist with colorectal expertise and a medical oncologist working within a multidisciplinary team that may also include a radiation oncologist, a gastroenterologist, a radiologist, and a pathologist. For rectal cancer in particular, a colorectal surgeon experienced in total mesorectal excision and related techniques is an important consideration.
How do I choose a doctor for Colorectal Cancer?
When comparing providers, look for a surgeon with demonstrable experience in colorectal cancer resection and minimally invasive (laparoscopic or robotic) techniques, and confirm that the centre offers true multidisciplinary tumour board review, access to medical oncology and molecular testing, and a clear plan for post-treatment surveillance and follow-up.
What documents do international patients need to share for a medical evaluation?
Share a concise medical summary, symptom timeline, previous diagnoses, investigation and imaging reports, procedure or biopsy reports where relevant, current medicines, allergies and related treatment records. Provide clear copies with translations when needed. The reviewing doctor may request additional information before giving an opinion.
How does GAF Healthcare help international patients plan treatment in India?
Our care coordination team can review the initial information, help identify suitable doctors and hospitals, request a medical opinion where available, explain next steps and indicative cost information, and support practical planning before travel. A remote opinion does not replace an in-person examination or emergency care.